Experiment 69516
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Trifolium pratense (FABACEAE) |
| Citation | ATKINSON,C: WARREN,RML: SALA,E: DOWSETT,M: DUNNING,AM: HEALEY,CS: RUNSWICK,S: DAY,NE: BINGHAM,SA:. (2004). RED CLOVER-DERIVED ISOFLAVONES AND MAMMOGRAPHIC BREAST DENSITY: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL [ISRCTN42940165].. 6(3) |
| Amount utilized | |
| Compound isolated | |
| Disease | SIGNIFICANT TREATMENT EFFECTS ON OESTRADIOL, FSH OR LH (ASSESSED ONLY IN POSTMENOPAUSAL WOMEN), OR ON LYMPHOCYTE TYROSINE KINASE ACTIVITY. BASELINE LEVELS OF MENOPAUSAL SYMPTOMS WERE LOW AND THERE WERE NO STATISTICALLY SIGNIFICANT TREATMENT DENSITY DECREASED IN BOTH GROUPS BUT THE DIFFERENCE BETWEEN THE TREATMENT AND PLACEBO WAS NOT STATISTICALLY SIGNIFICANT. THERE WAS A SIGNIFICANT INTERACTION BETWEEN TREATMENT GROUP AND OESTROGEN RECEPTOR (ESR1). THERE WERE NO STATISTICALLY A TOTAL OF 205 WOMEN (AGE 49-65) WITH WOLFE P2 OR DY MAMMOGRAPHIC BREAST PATTERNS WERE RANDOMLY ASSIGNED TO RECEIVE EITHER A RED CLOVER DERIVED ISOFLAVONE TABLET (26 MG BIOCHANIN A, 16 MG FORMONONETIN, 1 MG GENISTEIN AND 0.5 MG DAIDZEIN) OR |
| Dose amount | 43.5 MG |
| Number | 1 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | ISOFLAVONE FRACTION |
| Gender | FEMALE |